These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16775356)

  • 1. Structure-based mutational analysis of the NS3 helicase from dengue virus.
    Sampath A; Xu T; Chao A; Luo D; Lescar J; Vasudevan SG
    J Virol; 2006 Jul; 80(13):6686-90. PubMed ID: 16775356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase/nucleoside triphosphatase at a resolution of 1.8 A.
    Yamashita T; Unno H; Mori Y; Tani H; Moriishi K; Takamizawa A; Agoh M; Tsukihara T; Matsuura Y
    Virology; 2008 Apr; 373(2):426-36. PubMed ID: 18201743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the nucleoside triphosphatase, RNA triphosphatase, and unwinding activities of the helicase domain of dengue virus NS3 protein.
    Wang CC; Huang ZS; Chiang PL; Chen CT; Wu HN
    FEBS Lett; 2009 Feb; 583(4):691-6. PubMed ID: 19166847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.
    Murthy HM; Judge K; DeLucas L; Padmanabhan R
    J Mol Biol; 2000 Aug; 301(4):759-67. PubMed ID: 10966782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the DExH motif of the Japanese encephalitis virus and hepatitis C virus NS3 proteins in the ATPase and RNA helicase activities.
    Utama A; Shimizu H; Hasebe F; Morita K; Igarashi A; Shoji I; Matsuura Y; Hatsu M; Takamizawa K; Hagiwara A; Miyamura T
    Virology; 2000 Aug; 273(2):316-24. PubMed ID: 10915602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3.
    Zhong W; Ingravallo P; Wright-Minogue J; Skelton A; Uss AS; Chase R; Yao N; Lau JY; Hong Z
    Virology; 1999 Sep; 261(2):216-26. PubMed ID: 10497107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution structure and backbone dynamics of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase.
    Liu D; Wang YS; Gesell JJ; Wyss DF
    J Mol Biol; 2001 Nov; 314(3):543-61. PubMed ID: 11846566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue neurovirulence in mice: identification of molecular signatures in the E and NS3 helicase domains.
    Bordignon J; Strottmann DM; Mosimann AL; Probst CM; Stella V; Noronha L; Zanata SM; Dos Santos CN
    J Med Virol; 2007 Oct; 79(10):1506-17. PubMed ID: 17705192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication.
    Matusan AE; Pryor MJ; Davidson AD; Wright PJ
    J Virol; 2001 Oct; 75(20):9633-43. PubMed ID: 11559795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.
    Yin Z; Patel SJ; Wang WL; Chan WL; Ranga Rao KR; Wang G; Ngew X; Patel V; Beer D; Knox JE; Ma NL; Ehrhardt C; Lim SP; Vasudevan SG; Keller TH
    Bioorg Med Chem Lett; 2006 Jan; 16(1):40-3. PubMed ID: 16246563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RNA helicase, nucleotide 5'-triphosphatase, and RNA 5'-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core.
    Benarroch D; Selisko B; Locatelli GA; Maga G; Romette JL; Canard B
    Virology; 2004 Oct; 328(2):208-18. PubMed ID: 15464841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of surface basic amino acids of dengue virus NS3 helicase in viral RNA replication and enzyme activities.
    Chiang PY; Wu HN
    FEBS Lett; 2016 Jul; 590(14):2307-20. PubMed ID: 27273003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus NS3 RNA helicase activity is modulated by the two domains of NS3 and NS4A.
    Kuang WF; Lin YC; Jean F; Huang YW; Tai CL; Chen DS; Chen PJ; Hwang LH
    Biochem Biophys Res Commun; 2004 Apr; 317(1):211-7. PubMed ID: 15047170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of classical swine fever virus (CSFV) nonstructural protein 3 (NS3) helicase activity and its modulation by CSFV RNA-dependent RNA polymerase.
    Wen G; Xue J; Shen Y; Zhang C; Pan Z
    Virus Res; 2009 Apr; 141(1):63-70. PubMed ID: 19185595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.
    Yin Z; Patel SJ; Wang WL; Wang G; Chan WL; Rao KR; Alam J; Jeyaraj DA; Ngew X; Patel V; Beer D; Lim SP; Vasudevan SG; Keller TH
    Bioorg Med Chem Lett; 2006 Jan; 16(1):36-9. PubMed ID: 16246553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the domain interactions between the protease and helicase of NS3 in dengue and hepatitis C virus.
    Rosales-León L; Ortega-Lule G; Ruiz-Ordaz B
    J Mol Graph Model; 2007 Jan; 25(5):585-94. PubMed ID: 16762573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral NS3 helicase activity is inhibited by peptides reproducing the Arg-rich conserved motif of the enzyme (motif VI).
    Borowski P; Heising MV; Miranda IB; Liao CL; Choe J; Baier A
    Biochem Pharmacol; 2008 Jul; 76(1):28-38. PubMed ID: 18479669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the West Nile virus protease substrate specificity and inhibitors.
    Mueller NH; Yon C; Ganesh VK; Padmanabhan R
    Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.